0001894562-24-000016.txt : 20240227 0001894562-24-000016.hdr.sgml : 20240227 20240227093521 ACCESSION NUMBER: 0001894562-24-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240225 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gottesdiener Keith Michael CENTRAL INDEX KEY: 0001615856 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41536 FILM NUMBER: 24682694 MAIL ADDRESS: STREET 1: 900 FIFTH AVENUE STREET 2: #8C CITY: NEW YORK STATE: NY ZIP: 10021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prime Medicine, Inc. CENTRAL INDEX KEY: 0001894562 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-465-0013 MAIL ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wk-form4_1709044527.xml FORM 4 X0508 4 2024-02-25 0 0001894562 Prime Medicine, Inc. PRME 0001615856 Gottesdiener Keith Michael C/O PRIME MEDICINE, INC. 21 ERIE STREET CAMBRIDGE MA 02139 1 1 0 0 See Remarks 0 Stock Option (right to buy) 8.32 2024-02-25 4 A 0 100000 0 A 2034-02-25 Common Stock 100000 100000 D 1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 25, 2024, subject to the Reporting Person's continued service on each such vesting date. Not reported herein are performance-based options awarded to the Reporting Person on the same transaction date, which vest upon the achievement of certain performance criteria. As of the transaction date, the performance criteria for such performance-based options have not yet been satisfied. President and Chief Executive Officer /s/ Karen Brown, attorney-in-fact 2024-02-27